InfinaLife+

Description

InfinaLife+ is a three-component metabolic scaffold built around nicotinic acid, free-form L-tryptophan, and folic acid — three upstream inputs selected for their central relevance to metabolic continuity, redox balance, and precursor sufficiency.

Together, these three identified components form a prime upstream framework underpinning NAD biology, redox chemistry, and metabolic homeostasis.

–

The interplay between EXCLUSIVELY flush niacin (nicotinic acid), L-tryptophan, and folic acid — as choreographed through GPR109A (HCAR2) — reveals a coupled mechanism along a metabolic axis that fine-tunes energy metabolism and advances superhuman powers.

L-Tryptophan, in higher order beings, evolved to be utilized—by way of simply its adequate availability (in its free-form) through plasma—to serve as precursor in conversion to serotonin by way of serving as the substrate herein forming a complex at equilibrium with specifically folic acid. This high-level biochemical choreography enables cell/tissue damage and stress to get absorbed by tryptophan and given off as free radical electrons to folic acid, signaled in this fashion via GPR109A expresson, and ultimately released out the organism system as thermal energy (flush), and without limitation, over this redox cycling process as folate is reduced + methylated + cycled through purine synthesis, while serotonin is being made — powered forward by unleashed generation of nicotinic acid-NAD+ proton motive force by binding and activation of GPR109A. This all to harness rejuvenation and immortality.

Tryptophan—as if it’s a token but in limited supply needed to have/acquire enough of to counter oxidation and cellular failure that imminently runs out and must be reinstated to pay back the debt of unaddressed inflammation, cunningly through its orbital shell electron arranged geometry—is the regulator of immune-metabolic signaling.

Most profoundly in the context of GPR109A, L-tryptophan’s role extends beyond substrate status — it fuels the synthesis of serotonin, which, through 5-HT receptor signaling, modulates microglial inflammation and IDO expression. This creates a feedback loop where GPR109A activation reduces inflammatory responses, favoring tryptophan metabolism toward serotonin rather than kynurenine, thereby supporting redox homeostasis.

Folic acid plays a central role in this equilibrium by enabling methylation cycles that support the regeneration of tetrahydrobiopterin (BH4), a critical cofactor for tryptophan hydroxylase (TPH) — the enzyme that converts tryptophan to 5-HT. Without adequate BH4, TPH activity declines, shifting tryptophan metabolism toward kynurenine and increasing oxidative stress. This imbalance promotes IDO expression, further depleting tryptophan and reducing serotonin synthesis.

The diagram shows that folic acid and L-tryptophan can form an ion-associated complex, potentially stabilizing their interaction in the cellular environment. This complex may enhance the efficiency of their metabolic integration — particularly in the context of redox regulation. When folic acid is sufficient, it supports the reduction of free radical electrons, clears ROS, and enables the proper recycling of BH4, which in turn sustains TPH activity and serotonin production.

This creates a self-reinforcing cycle: GPR109A activation reduces inflammation, lowers IDO, and shifts tryptophan metabolism toward serotonin. Serotonin supports GPR109A expression via 5-HT receptor signaling, while folic acid maintains the metabolic infrastructure needed for this shift. Without folic acid, the cycle breaks — ROS accumulate, BH4 is depleted, and GPR109A expression remains suppressed.

Thus, restoring GPR109A isn’t just about adding niacin. It requires re-establishing the metabolic balance that allows tryptophan to be used for serotonin rather than kynurenine, and folic acid to support the redox and methylation processes that make this shift possible. Only then can the system regain its ability to regulate lipolysis and energy homeostasis.

The reason folic acid — not “active folate” — is required here is because the system is broken at the level of *reduction*, not just availability.

In metabolic dysfunction (obesity, T2DM), the cellular redox environment is oxidized. This means:
– Endogenous folate (5-MTHF, the “active” form) gets oxidized and inactivated
– The enzymes that reduce folic acid to 5-MTHF (like MTHFR) are impaired due to low NADPH
– NADPH itself is depleted because NAD+ is low — which is why niacin supplementation is needed in the first place

So “active folates” aren’t lost because they’re not being made — they’re lost because they’re being *destroyed* by oxidative stress, and the system can’t regenerate them without NADPH — which requires NAD+ from niacin.

Similarly, L-tryptophan isn’t just “low” — it’s *functionally unavailable*. When bound to albumin or sequestered in protein, it can’t enter cells or be converted to serotonin or NAD+. Only free-form L-tryptophan can be taken up, metabolized, and used to support BH4, NAD+, and redox balance.

And niacin? It’s not just about NAD+ — it’s about activating GPR109A, which suppresses IDO, which preserves tryptophan, which supports serotonin, which supports BH4, which supports TPH, which supports redox — which then allows folic acid to be reduced to active folate.

So yes — you must supplement all three in free, bioavailable forms:
– **Folic acid** — because it’s stable, less labile, and can be reduced *if* NAD+ and redox are restored
– **Free L-tryptophan** — because bound forms can’t be metabolized in a stressed cell
– **Nicotinic acid** — because it’s the only precursor that activates GPR109A, which sets the whole cascade in motion

This isn’t about “natural vs synthetic” — it’s about *functional restoration*. The body can’t make active folate or use bound tryptophan when the system is oxidized and NAD+ is depleted. You have to rebuild the foundation — with free-form, bioavailable precursors — to restart the cycle.

Nicotinic acid (NA) [immediate-release, crystalline niacin] isn’t just a ligand for GPR109A; it’s the foundational precursor for the entire NAD(P)H redox system that powers the cycle. As shown in the diagram, NA enters the cell and is converted via NAPRT → NMNAT → NAD, which then fuels multiple branches: NADP, NAADP, and NADPH — all critical for redox control.

NADPH is the reducing equivalent that directly regenerates BH4 from BH2 via DHFR and other reductases. Without sufficient NADPH, BH4 remains oxidized, TPH stalls, and tryptophan can’t be converted to serotonin. Instead, it gets shunted into the kynurenine pathway — increasing IDO, ROS, and inflammation, which further suppresses GPR109A.

The diagram also shows that NAADP — derived from NA via NADSYN — is essential for calcium signaling from endolysosomes, which modulates phagocytosis, autophagy, and inflammatory responses. This ties back to microglial and adipose cell function: if NAADP is low, calcium signaling is impaired, endolysosomal clearance fails, and ROS accumulate — again blocking GPR109A re-expression.

So nicotinic acid isn’t optional — it’s the metabolic engine. It provides:
– NAD → NADP → NADPH to reduce BH2 → BH4
– NAADP to regulate calcium and lysosomal function
– Substrate for NAD+ pools that sustain energy metabolism and sirtuin activity

Without adequate NA, even with folic acid and tryptophan, the system can’t generate the reducing power or signaling molecules needed to clear ROS, recycle BH4, sustain TPH, or support serotonin synthesis — all of which are required to restore GPR109A expression and function.

This isn’t supplementation. It’s metabolic reconstruction — and nicotinic acid is the core scaffold.

GPR109A is not in the diagram — but its activation is the trigger that sets the entire downstream cascade in motion.

GPR109A is a G-protein coupled receptor on the plasma membrane of adipocytes, macrophages, and microglia. When activated by nicotinic acid (not nicotinamide, not NR), it signals through Gi to:
– Inhibit adenylate cyclase → reduce cAMP → suppress lipolysis
– Activate β-arrestin → modulate inflammatory pathways (e.g., NF-κB, IDO)
– Downregulate IDO → shift tryptophan metabolism toward serotonin, away from kynurenine

This is critical — because only nicotinic acid activates GPR109A. Nicotinamide, NR, NMN — they bypass this receptor entirely. They make NAD+, yes — but they don’t trigger the anti-inflammatory, serotonin-sparing, IDO-suppressing, GPR109A-dependent signaling that reprograms the metabolic environment.

So while the diagram shows NA → NAD → NADP → NAADP → endolysosomal Ca²⁺ → phagocytosis/clearance, that pathway is *only* fully engaged when GPR109A is activated — because without it, IDO stays high, tryptophan is depleted, ROS accumulate, and the cell remains in a pro-inflammatory, redox-stressed state that blocks NADK activity and NAADP generation.

—

2. Where does GPR109A fit in the diagram? It’s upstream — the switch that enables the system to function.

Think of GPR109A as the “gatekeeper” that allows the cell to transition from a stressed, inflammatory, IDO-high state to a homeostatic, serotonin-sustaining, ROS-clearing state. Once activated, it:
– Reduces IDO → preserves free L-tryptophan
– Lowers ROS → allows NADK to convert NAD → NADP efficiently
– Enables NADP to signal back to the NAPRT pathway — not to make more NMN (which would be futile in a redox-stressed cell), but to divert NA into the endolysosomal NAAD → NAADP pathway

This is key: NAPRT expression is upregulated in response to NADP availability — but only if the cell is in a low-inflammatory, high-serotonin state (i.e., GPR109A activated). Without GPR109A signaling, NAPRT is suppressed, and NA gets shunted into futile cycles or excreted.

—

3. Free L-tryptophan fits here: it’s the fuel for serotonin synthesis — but only if IDO is suppressed (via GPR109A) and BH4 is regenerated (via NADPH from NADP).

In the diagram, L-tryptophan isn’t shown — but it’s the missing link. Without GPR109A activation, IDO is high → tryptophan is converted to kynurenine → serotonin drops → BH4 isn’t sustained → TPH stalls → ROS rise → NADK is inhibited → NADP drops → NAADP can’t form → endolysosomal Ca²⁺ signaling fails → phagocytosis/clearance collapses.

So free L-tryptophan isn’t just a precursor — it’s a *sensor* of metabolic health. Its depletion signals inflammation. Its restoration — via GPR109A activation — allows serotonin to be made, which supports GPR109A expression (positive feedback), and enables the redox cycle to continue.

—

4. Folic acid is the scaffold — it enables the methylation and redox cycling that keeps BH4, NADP, and NADPH in flux.

Folate drives the regeneration of BH4 from BH2 via DHFR, which requires NADPH. Without folate, BH4 stays oxidized, TPH stalls, serotonin drops, IDO rises — and the cycle collapses. Folate also supports the methylation of homocysteine → methionine → SAM → epigenetic reactivation of GPR109A and other metabolic genes.

So folate isn’t just “helping” — it’s the structural support that allows the entire system to function. Without it, even with NA and tryptophan, the redox cycle breaks.

—

5. Why nicotinic acid is non-replaceable:

– It’s the only NAD precursor that activates GPR109A → suppresses IDO → preserves tryptophan → enables serotonin → supports BH4 → sustains NADK → generates NADP → fuels NAADP → restores endolysosomal function.
– Other precursors (nicotinamide, NR, NMN) make NAD+ — but they don’t activate GPR109A, so they can’t trigger this cascade. They may even worsen inflammation by inhibiting sirtuins or PARPs in a stressed cell.

—

In summary:

GPR109A is the master switch. Nicotinic acid is the only key that turns it. Once turned, it:
– Preserves L-tryptophan by suppressing IDO
– Enables serotonin synthesis via BH4 regeneration (fueled by NADPH from NADP)
– Allows NADK to convert NAD → NADP (contingent on low ROS, high folate)
– Signals NAPRT to divert NA into endolysosomal NAAD → NAADP (via CD38 and base exchange)
– Restores Ca²⁺ signaling, phagocytosis, and clearance — breaking the cycle of oxidative stress and inflammation

Without nicotinic acid → no GPR109A activation → no tryptophan preservation → no serotonin → no BH4 → no NADP → no NAADP → no endolysosomal function → no metabolic restoration.

This is why niacin isn’t just another NAD precursor — it’s the only one that engages the receptor that reprograms the entire system. Additionally, this is how restoring available L-tryptophan together with folic acid becomes indispensable alongside.

InfinaLife+ appropriately unites these three identified precursor essential nutrient growth factors to provide a professionally compounded, completely pure, easy blend.

xxx,

forever…

Dr. Dmitry Kats PhD, MPH